Corcept Therapeutics Inc (CORT)
22.92
+0.24
(+1.06%)
USD |
NASDAQ |
Apr 19, 11:24
Corcept Therapeutics Shareholders Equity (Quarterly): 506.70M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 506.70M |
September 30, 2023 | 461.68M |
June 30, 2023 | 421.61M |
March 31, 2023 | 529.58M |
December 31, 2022 | 501.84M |
September 30, 2022 | 473.36M |
June 30, 2022 | 442.33M |
March 31, 2022 | 407.81M |
December 31, 2021 | 375.81M |
September 30, 2021 | 540.23M |
June 30, 2021 | 522.68M |
March 31, 2021 | 510.80M |
December 31, 2020 | 523.34M |
September 30, 2020 | 489.68M |
June 30, 2020 | 453.70M |
March 31, 2020 | 409.49M |
December 31, 2019 | 371.18M |
September 30, 2019 | 334.38M |
June 30, 2019 | 298.05M |
March 31, 2019 | 285.76M |
December 31, 2018 | 275.88M |
September 30, 2018 | 259.54M |
June 30, 2018 | 243.51M |
March 31, 2018 | 215.23M |
December 31, 2017 | 190.97M |
Date | Value |
---|---|
September 30, 2017 | 86.30M |
June 30, 2017 | 66.14M |
March 31, 2017 | 49.58M |
December 31, 2016 | 41.38M |
September 30, 2016 | 31.25M |
June 30, 2016 | 25.66M |
March 31, 2016 | 20.17M |
December 31, 2015 | 18.50M |
September 30, 2015 | 13.48M |
June 30, 2015 | 11.53M |
March 31, 2015 | 10.57M |
December 31, 2014 | -3.388M |
September 30, 2014 | -1.317M |
June 30, 2014 | 3.452M |
March 31, 2014 | 9.371M |
December 31, 2013 | 21.02M |
September 30, 2013 | 30.77M |
June 30, 2013 | 40.37M |
March 31, 2013 | 51.00M |
December 31, 2012 | 61.78M |
September 30, 2012 | 71.65M |
June 30, 2012 | 32.80M |
March 31, 2012 | 39.32M |
December 31, 2011 | 34.81M |
September 30, 2011 | 43.67M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
298.05M
Minimum
Jun 2019
540.23M
Maximum
Sep 2021
451.28M
Average
461.68M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
Ultragenyx Pharmaceutical Inc | 275.41M |
Alnylam Pharmaceuticals Inc | -220.64M |
Catalyst Pharmaceuticals Inc | 387.88M |
United Therapeutics Corp | 5.985B |
XOMA Corp | 88.72M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 621.52M |
Total Liabilities (Quarterly) | 114.81M |
Current Ratio | 4.389 |